Neisseria gonorrhoeae

Neisseria gonorrhoeae Overview

Neisseria gonorrhoeae often presents asymptomatically but can cause severe reproductive complications and has shown alarming antimicrobial resistance (CDC, 2025). PCR detection enables timely, appropriate therapy and supports surveillance efforts (Workowski et al., 2021).

References

Centers for Disease Control and Prevention (CDC). (2025). Gonorrhea – CDC detailed fact sheet.

Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park I., Reno, H., Jonathan M. Zenilman J.M.,Bolan, G. A. (2021). Sexually transmitted infections treatment guidelines, 2021. MMWR Recommendations and Reports, 70(4), 1–187.

Products used to detect Neisseria gonorrhoeae

STI PCR Panel – Large

The STI large PCR panel is designed for multiplex in vitro assessment of 9 common microbiota typically associated with transmission by sexual activity, using real-time PCR.

Women’s Health PCR Panel – Large

The women’s health large PCR panel is designed for multiplex in vitro assessment of 37 common vaginal microbiota and resistance markers, using real-time PCR.